Drugs / ONO-2808
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04578028 | Aug 2020 → Aug 2021 | neurodegenerative disease | Ono Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT05923866 | Sep 2023 → Sep 2025 overdue | multiple system atrophy | Ono Pharmaceutical Co., Ltd. | Active not recruiting | No outcome recorded |
News releases announcing trial results or a regulatory action · 2
| Date | Issuer | Release |
|---|---|---|
| 2026-05-28 | Ono Pharmaceutical Co., Ltd. | Results Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 (S1P5 Receptor Agonist) in Multiple System Atrophy at the 7th World Parkinson Congress (WPC) ono-pharma.com ↗
TEAEs incidence was similar to placebo (91%, n=21/23) and ONO-2808 (93%, n=64/69), with no unexpected safety signals. |
| 2025-10-09 | Ono Pharmaceutical Co., Ltd. | Results Ono Announces Encouraging Efficacy Signals of ONO-2808, a S1P5 Receptor Agonist, in an interim analysis of Ongoing Phase 2 Clinical Trial in Patients with Multiple System Atrophy ono-pharma.com ↗ |
All press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2026-05-28 | Ono Pharmaceutical Co., Ltd. | Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 (S1P5 Receptor Agonist) in Multiple System Atrophy at the 7th World Parkinson Congress (WPC) ono-pharma.com ↗ |
| 2025-10-09 | Ono Pharmaceutical Co., Ltd. | Ono Announces Encouraging Efficacy Signals of ONO-2808, a S1P5 Receptor Agonist, in an interim analysis of Ongoing Phase 2 Clinical Trial in Patients with Multiple System Atrophy ono-pharma.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ONO-2808 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05923866 ↗ |
| Route | Oral | “Single and Multiple Oral Doses of ONO-2808” NCT04578028 ↗ |